Our results reveal that, in DLBC, LAML, and THYM, TREM2 expression was significantly positively correlated with immune scores, as well as with stromal scores in pan-cancer analysis, except for in CHOL, DLBC, MESO, and LAML. This evidence concerns the gene TREM2 and cancer.